464 related articles for article (PubMed ID: 31440038)
1. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
[No Abstract] [Full Text] [Related]
2. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress.
Xu Y; Yuan Q; Cao S; Cui S; Xue L; Song X; Li Z; Xu R; Yuan Q; Li R
Biochem Biophys Res Commun; 2020 Sep; 529(4):998-1004. PubMed ID: 32819611
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation.
Zhu Z; Li J; Zhang X
Med Sci Monit; 2019 Mar; 25():2132-2140. PubMed ID: 30901320
[TBL] [Abstract][Full Text] [Related]
4. Pelargonic acid vanillylamide and rosuvastatin protect against oxidized low-density lipoprotein-induced endothelial dysfunction by inhibiting the NF-κB/NLRP3 pathway and improving cell-cell junctions.
Sivasinprasasn S; Wikan N; Tocharus J; Chaichompoo W; Suksamrarn A; Tocharus C
Chem Biol Interact; 2021 Aug; 345():109572. PubMed ID: 34217687
[TBL] [Abstract][Full Text] [Related]
5. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
Yao Y; Wang Y; Zhang Y; Liu C
Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
[TBL] [Abstract][Full Text] [Related]
6. Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNF
Wang S; Xie X; Lei T; Zhang K; Lai B; Zhang Z; Guan Y; Mao G; Xiao L; Wang N
Mol Pharmacol; 2017 Sep; 92(3):256-264. PubMed ID: 28546421
[TBL] [Abstract][Full Text] [Related]
7. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.
Dai Y; Cao Y; Zhang Z; Vallurupalli S; Mehta JL
Cardiovasc Drugs Ther; 2017 Feb; 31(1):19-27. PubMed ID: 28084571
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium.
Zhao Y; Li Q; Zhao W; Li J; Sun Y; Liu K; Liu B; Zhang N
J Ethnopharmacol; 2015 Jul; 169():210-8. PubMed ID: 25922268
[TBL] [Abstract][Full Text] [Related]
10. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of astragaloside IV against benzo[a]pyrene induced endothelial progenitor cell dysfunction.
Ji K; Chen J; Hu J; Xue Y; Yin R; Lu Q; Wu W; Wang G; Wang X; Song X; Li J; Liao L; Tang J
Life Sci; 2015 Jul; 132():13-9. PubMed ID: 25916804
[TBL] [Abstract][Full Text] [Related]
12. L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages.
Yang TC; Chang PY; Lu SC
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H265-H274. PubMed ID: 27864235
[TBL] [Abstract][Full Text] [Related]
13. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A.
Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y
Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273
[TBL] [Abstract][Full Text] [Related]
14. Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress.
Hang L; Peng Y; Xiang R; Li X; Li Z
Drug Des Devel Ther; 2020; 14():731-744. PubMed ID: 32158192
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-
Leng B; Zhang Y; Liu X; Zhang Z; Liu Y; Wang H; Lu M
Mediators Inflamm; 2019; 2019():1082497. PubMed ID: 30906223
[TBL] [Abstract][Full Text] [Related]
16. Quercitrin treatment protects endothelial progenitor cells from oxidative damage via inducing autophagy through extracellular signal-regulated kinase.
Zhi K; Li M; Bai J; Wu Y; Zhou S; Zhang X; Qu L
Angiogenesis; 2016 Jul; 19(3):311-24. PubMed ID: 27017346
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-223 abrogates NLRP3 inflammasome-mediated pyroptosis to attenuate oxidized low-density lipoprotein (ox-LDL)-induced cell death in human vascular endothelial cells (ECs).
Wang X; Li X; Wu Y; Song Y
In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):670-679. PubMed ID: 32914384
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
19. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430
[TBL] [Abstract][Full Text] [Related]
20. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress.
Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S
Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
